PPARG and hepatocellular carcinoma: PPARγ signaling also affects the metabolic changes in the HCC-microenvironment, as evidenced by studies showing that inhibiting the PPARγ-ACLY/ACC axis can prevent the de novo synthesis of fatty acids, thereby inhibiting the occurrence and progression of HCC29.